|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-11-29
|
|
pubmed:abstractText |
Patients with Down syndrome (DS) and standard risk (SR) acute lymphoblastic leukemia (ALL-DS) are reported to have inferior event free (EFS) and overall survival (OS) compared to patients without DS (ALL-NDS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1545-5009
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
(c) 2004 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
21-8
|
|
pubmed:dateRevised |
2009-1-12
|
|
pubmed:meshHeading |
pubmed-meshheading:15368546-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15368546-Child,
pubmed-meshheading:15368546-Child, Preschool,
pubmed-meshheading:15368546-Disease-Free Survival,
pubmed-meshheading:15368546-Down Syndrome,
pubmed-meshheading:15368546-Female,
pubmed-meshheading:15368546-Humans,
pubmed-meshheading:15368546-Infant,
pubmed-meshheading:15368546-Male,
pubmed-meshheading:15368546-Ploidies,
pubmed-meshheading:15368546-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:15368546-Prognosis,
pubmed-meshheading:15368546-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
|
|
pubmed:affiliation |
Pediatric Hematology/Oncology/BMT, University of Colorado Health Sciences Center, Denver, Colorado, USA. bassal.mylene@tchden.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
